Asker Healthcare Group has acquired novus med for an undisclosed amount, in a transaction that will expand Asker's footprint in the medical device sector. novus med is a leading UK medical device company specialising in the provision of medical and surgical innovation. The acquisition sees Asker Healthcare Group, a prominent entity in the healthcare solutions market, integrate novus med's specialized portfolio and UK market presence. This is a corporate acquisition, not a funding round.
novus med focuses on delivering innovative technologies for minimally invasive surgery in operating theatres and outpatient departments. Their offerings include a wide range of products such as single-use flexible endoscopes, advanced laser systems, access sheaths, laparoscopic instruments, and patient positioning systems. The company prides itself on sourcing technological innovation globally to provide solutions to patients and clinicians that deliver sustainable value and cost savings to the healthcare system, augmented by strong customer support.
This strategic acquisition is expected to strengthen Asker Healthcare Group's capabilities and market reach within the highly specialized medical device sector. By bringing novus med into its portfolio, Asker gains a robust distribution network in the UK and a direct presence in key areas of minimally invasive surgery. novus med’s established relationships with "UK exclusive partners" and its expertise in cutting-edge surgical tools represent a significant addition to Asker's overall healthcare offering.
The synergy between the two entities is anticipated to result in a more comprehensive and diversified product and service portfolio. Asker Healthcare Group is set to leverage novus med’s focus on technological innovation and customer-centric approach to enhance its market position. The combined entity aims to deliver broader solutions and efficiencies to healthcare providers, supporting improved patient outcomes and operational value across the healthcare landscape. The acquisition positions the combined operations for continued growth in the evolving medical technology market.